e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Clinical aspects of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tolerability of modafinil in disorders of sleep and wakefulness
J. R. L. Schwartz, M. J. Thorpy, J. Black, M. K. Erman (Oklahoma City, Bronx, Stanford, San Diego, United States Of America)
Source:
Annual Congress 2004 - Clinical aspects of OSA
Session:
Clinical aspects of OSA
Session type:
Thematic Poster Session
Number:
798
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. R. L. Schwartz, M. J. Thorpy, J. Black, M. K. Erman (Oklahoma City, Bronx, Stanford, San Diego, United States Of America). Tolerability of modafinil in disorders of sleep and wakefulness. Eur Respir J 2004; 24: Suppl. 48, 798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Efficacy and safety of modafinil as an adjunctive therapy for excessive sleepiness associated with obstructive sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 116s
Year: 2004
Feasibility and patient tolerability of transcutaneous electrical stimulation in obstructive sleep apnoea
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Is waking electroencephalographic activity a predictor of daytime sleepiness in sleep-related breathing disorders?
Source: Eur Respir J 2002; 19: 645-652
Year: 2002
Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
The efficacy of oral appliance in patients with severe obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Management of insomnia in sleep disordered breathing
Source: Eur Respir Rev, 28 (153) 190080; 10.1183/16000617.0080-2019
Year: 2019
Efficacy and safety of single-use suvorexant for insomnia during in-laboratory polysomnography in patients with obstructive sleep apnea: A feasibility study
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Cerebral oxygenation during REM sleep in obstructive sleep apnoea is associated with daytime neuropsychological function
Source: Eur Respir J 2004; 24: Suppl. 48, 444s
Year: 2004
Sleep apnea as a cause of sleep misperception in elderly insomnia patients
Source: International Congress 2017 – Phenotyping obstructive sleep apnoea
Year: 2017
The relationship between anxiety, depression and subjective sleep quality on sleep apnea patients
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Rapid eye movement sleep behaviour disorder and obstructive sleep apnoea
Source: 5th Sleep and Breathing Conference
Year: 2019
Insomnia in sleep disordered breathing
Source: International Congress 2017 – Sleep and Breathing
Year: 2017
Relation between sleep bruxism and sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 494s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept